메뉴 건너뛰기





Volumn 4, Issue 1, 2012, Pages 4-13

World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA

Author keywords

Antibody engineering; Bispecific antibodies; Therapeutic antibodies

Indexed keywords

BISPECIFIC ANTIBODY; BLINATUMOMAB; BW835 MONOCLONAL ANTIBODY; CATUMAXOMAB; CD32BXCD79B DART ANTIBODY; CD33 ANTIGEN; CETUXIMAB; COVA 301; EKTOMUN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERTUMAXOMAB; FC RECEPTOR; HLA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; KAPPA LAMBDA BODY; MEHD 7945 A; MODULAR BISPECIFIC ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; T LYMPHOCYTE RECEPTOR; TRIOMAB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

EID: 84856808226     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.4.1.18821     Document Type: Conference Paper
Times cited : (45)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.